As part of the Inflation Reduction Act, manufacturers are required to pay a rebate to Medicare if a drug's price increase exceeds the rate of inflation. CMS said it intends to send the first invoices ...

Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...

Several common drugs will be cheaper next year under Medicare, from weight-loss drug Ozempic to breast-cancer medication ...

Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than wh | CMS' ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...

Trump and Biden administration policies seeking to rein in high prescription drug prices are slated to go into effect in the new year, setting up various overlapping plans with which drug companies ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS will use the annual formulary review process to ensure that plans cover all ...

Medicare inflation rebates did not significantly curb price increases for top-selling drugs, despite the Inflation Reduction Act's intentions. Part D drugs showed a slight association between Medicare ...